When you canvass other witnesses about that, it may be more productive for you, because we're not actually part of the negotiations that go on to that next step. I can certainly describe for you--and have to some small extent--the fact that we've received applications. We've sat down together with our colleagues in the commissioner's office and explained to the company how it all works and what each step involves. But the next step is the exchange between the generics and the brands in the country. We're not involved in that discussion.
On April 16th, 2007. See this statement in context.